The complete immunotherapy reference from basic science to clinical application Immunotherapy has transformed treatment approaches for cancer, autoimmune diseases, and infectious conditions, yet no single resource has unified its foundational immunology with advanced clinical applications. Frazer's Foundations of Immunotherapy addresses this absence, offering comprehensive coverage co-edited by Fernando Guimaraes, a leading immunotherapy expert and Ian Frazer, co-developer of the HPV vaccine Gardasil. With coverage of CAR T-cell therapy, NK cell therapies, precision immunotherapy, and the microbiome's role in treatment response, this text integrates evolving research with practical protocols for students, researchers, and clinicians. Readers will also find:
- Structured progression from basic immunology principles through cutting-edge therapeutic developments, bridging theory with clinical and research applications
- Coverage spanning cancer, autoimmune conditions, and infectious diseases rather than limiting scope to oncology immunotherapy approaches alone
- Practical clinical case studies demonstrating real-world application of immunotherapy principles across diverse patient populations
- Expert contributions from leading researchers from globally renowned research groups and institutions, ensuring authoritative, current content
- Extensive illustrations simplifying complex immunological concepts for advanced students, clinical trainees, and practicing professionals alike
This guide will benefit advanced students in biomedical and medical programs, immunology and oncology professionals, biotechnology researchers, and clinical trainees. Frazer's Foundations of Immunotherapy provides the structured pathway from fundamental principles to therapeutic applications that this rapidly evolving field demands.
Inhaltsverzeichnis
About the Editors xix
List of Contributors xx
Foreword xxiv
Preface xxv
Acknowledgements xxvi
PART I Foundations of Immunotherapy 1
CHAPTER 1 History and Development of Immunotherapies - Key Breakthroughs and Milestones, from Early Immunology to Contemporary Immunotherapy 3
Jean-Marc Cavaillon
Learning Objectives 3
1.1 Key Milestones in the History of Immunology 3
1.2 Variolation and Vaccination 6
1.3 Serotherapy 8
1.4 Anti-Tumour Activity of Bacteria, Bacterial Toxins, and Viruses 9
1.5 Immunoglobulin, Antibodies, and Monoclonal Antibodies 12
1.6 Harnessing and Targeting Cytokines 14
1.7 Targeting the Inflammatory Players 18
1.8 Cellular Therapies for Cancer 18
1.9 Neuromodulation of Inflammation 19
1.10 A Personal Concluding Remark 20
CHAPTER 2 Introduction to Immunology and Immune Modulation 34
Janin Chandra, Lakshita Patil, and Graham Leggatt
2.1 The Frontlines of Immune Defence 34
2.2 Pamps and Damps 35
2.3 Complement System 35
2.4 Innate Immune Cells 35
2.5 Antigen Presentation 38
2.6 Adaptive Immunity 38
2.7 Trained Immunity - a Different Kind of Immune Memory 44
2.8 Examples of Failing Immune Regulation 44
2.9 Case Study - Immune Modulation Gone Wrong 46
CHAPTER 3 Mechanisms of Immune Evasion and Immune Surveillance: Cellular Barriers to Immunotherapy 51
Marion F. Barros, Liwang Zhang, Jason J. Lee, Jenna S. Theron, Lixue Li, Shannon R. Joseph, and Fiona Simpson
3.1 Introduction 51
3.2 Tumour-Intrinsic Evasion Mechanisms 52
3.3 Tumour-Extrinsic Evasion Mechanisms 56
3.4 Parallels in Pathogens and Autoimmunity 59
3.5 Evasion of the Innate Immune System 60
PART II Immunotherapy in Cancer 67
CHAPTER 4 Cancer Immunotherapy: Key Concepts and Techniques 69
Denise Goh, Ng Kai Soon, Zhu Zhu, Rachel Elizabeth Ann Fincham, and Joe Yeong
4.1 Introduction 69
4.2 Approaches in Cancer Immunotherapy 70
4.3 Key Concepts in Immunotherapy 71
4.4 Key Techniques for Immunotherapy Assessment 75
4.5 Future Directions 80
CHAPTER 5 Immune Checkpoint Inhibitors in Cancer: Mechanisms, Clinical Use, and Challenges 85
Camille Hansen and Arabella Young
5.1 Introduction 85
5.2 The Discovery of Key Immune Checkpoints 87
5.3 Approved Indications and Biomarkers 88
5.4 Challenges and Controversies 90
5.5 Case Studies and Real-World Examples 94
5.6 Future Directions 95
CHAPTER 6 Advancements in CAR T and CAR NK Cell Therapies 103
Karen Slattery, Thomas J. Cole, and Phillip K. Darcy
6.1 Introduction 103
6.2 Armouring CAR T Cells to Enhance Therapeutic Efficacy 104
6.3 Tumour-Restricted Armouring - the Next Frontier of Enhanced CAR T Cells 106
6.4 Engaging CAR T Cells With Endogenous Immunity 107
6.5 Enhancing CAR T-Cell Efficacy Through Metabolism 108
6.6 Armouring CAR NK Cells for Increased Therapeutic Efficacy 110
6.7 Boosting CAR NK Cell Therapeutic Efficacy Through Metabolism 112
6.8 Future Directions for CAR T and CAR NK Cell Therapy 114
CHAPTER 7 Therapeutic Cancer Vaccines: Challenges and Successes in Cancer Immunotherapy 120
Riccardo Dolcetti
7.1 Introduction 120
7.2 Mechanism of Action 121
7.3 The Critical Choice of the Best Antigens for Vaccine Development 122
7.4 Vaccine Delivery Platforms 130
7.5 Case Studies 135
7.6 Current Challenges and Future Perspectives 136
7.7 Concluding Remarks 140
PART III Immunotherapy in Infectious Diseases 151
CHAPTER 8 Immunotherapy for Viral Infections: Mechanisms, Clinical Applications, and Future Directions 153
Stephanie Jost, Cordelia Manickam, and R. Keith Reeves
8.1 Introduction 153
8.2 Immunotherapies for Viral Infections in the Clinic 155
8.3 Challenges and Controversies 167
8.4 Future Directions 168
CHAPTER 9 Immunotherapy for Microbial Infections: Addressing Bacterial Resistance and Parasitic Infections with Immunotherapy 179
Christian R. Engwerda and Jessica A. Engel
9.1 Introduction 179
9.2 Immunotherapy for Microbial Infections 181
9.3 Challenges and Limitations 185
9.4 Future Directions 186
9.5 Case Studies and Real-World Examples 188
CHAPTER 10 Vaccine Development and Immune Response Optimisation 199
Limin Zhao, Jingru Gong, Ian H. Frazer, and Zhian Chen
10.1 Introduction 199
10.2 How the Immune System Responds to Vaccines 200
10.3 Next-Generation Vaccine Platforms and the Immunological Advantages 202
10.4 Outstanding Questions in Improving Vaccine Immunity 208
PART IV Immunotherapy in Transplantation Settings, Autoimmune, and Inflammatory Diseases 215
CHAPTER 11 Engineering Regulatory T Cells: Applications for Autoimmune Disorders 217
Leonardo M.R. Ferreira and Russell W. Cochrane
11.1 Introduction 217
11.2 Mechanisms of Treg-Mediated Suppression 218
11.3 Clinical Applications Across Autoimmune Diseases 220
11.4 Challenges and Future Directions 226
CHAPTER 12 Immunotherapy in Transplantation Settings 238
James W. Wells
12.1 Introduction 238
12.2 Key Milestones in Transplant Success 240
12.3 Clinical Applications 241
12.4 Challenges and Controversies 243
12.5 Future Directions 247
CHAPTER 13 Immunotherapy for the Global Prevention of Haemolytic Disease of the Foetus and Newborn 259
Behnaz Heydarchi and Ian P Wicks
13.1 Introduction 259
13.2 Molecular Features of RhD 261
13.3 Evolution of Therapy for the Prevention of HDFN 262
13.4 The Impact of HDFN 264
13.5 Maintaining the Supply of RhD-pIgG 265
13.6 Case Studies of Alternatives to RhD-pIgG 267
13.7 Challenges in Developing a New Immunotherapy for HDFN 269
13.8 Future Directions 271
CHAPTER 14 Advances in Engineered Immune Cells: Latest Advancements in CRISPR, CAR-T, and Other Immune Cell Engineering Techniques 280
Lamberto Torralba-Raga and Karl-Johan Malmberg
14.1 Introduction 280
14.2 Engineering Specificity and Functional Modalities 282
14.3 Engineering 'Smarter' Cells 285
14.4 Precision Engineering Tools 288
14.5 Conclusion 294
PART V Advanced Immunotherapy Techniques and Applications 303
CHAPTER 15 Personalised Immunotherapy and Biomarker-Driven Approaches 305
Naomi Berrell, Denise Goh, Clara Lawler, Meg L. Donovan, Joe Yeong, and Arutha Kulasinghe
15.1 Introduction 305
5.2 Spatial Transcriptomics 307
15.3 Spatial Proteomics 309
15.4 Metabolomics 310
15.5 Epigenomics 312
15.6 Challenges and Controversies 313
15.7 Future Directions 314
15.8 Case Studies and Real-World Examples 315
CHAPTER 16 Immunotherapy and the Microbiota: Exploring Microbiota-Immune Interactions and Their Impact on Immunotherapy Efficacy 321
Meriem Messaoudene and Marine Fidelle
16.1 Introduction 321
16.2 Physiological and Immunological Functions of the Gut Microbiota 322
16.3 Linking the Microbiome to Immunotherapy Efficacy in Cancer 324
16.4 Therapeutic Modulation or Protection of the Gut Microbiota to Enhance Immunotherapy Efficacy in Cancer 326
16.5 Challenges and Controversies 330
16.6 Future Directions 331
CHAPTER 17 Veterinary Immunotherapy 338
Alexandre Humbert, Marie Abitbol, and Carole Peroz
17.1 Introduction 338
17.2 Monoclonal Antibodies in the Treatment of Osteoarthritis 339
17.3 Monoclonal Antibodies in the Treatment of Canine Atopic Dermatitis 342
17.4 Anticancer Immunotherapies 343
17.5 Perspectives 346
CHAPTER 18 Emerging Immunotherapies and Future Horizons 352
Jingchen Zhou, Jiya Jose, Matt VanBrocklin, John D. Hooper, Brett M. Paterson, and Fernando Souza-Fonseca-Guimaraes
18.1 Introduction 352
18.2 Core Content Sections 355
18.3 Case Study 361
18.4 Challenges and Controversies 363
18.5 Future Direction 364
Key Terms & Definitions Sidebar 365
List of Abbreviations 366
Review Questions 367
References 367
Index 372